Published in Recent Pat DNA Gene Seq on January 01, 2008
Nano delivers big: designing molecular missiles for cancer therapeutics. Pharmaceutics (2011) 0.91
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol Hematol (2012) 0.88
Immunomodulatory effects of aqueous extract of Tridax procumbens in experimental animals. J Ethnopharmacol (2004) 1.14
Nano-vectors for efficient liver specific gene transfer. Int J Nanomedicine (2008) 1.11
Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs. J Control Release (2004) 1.10
Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int J Pharm (2003) 1.09
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine (2008) 1.08
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine (2006) 1.08
Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine (2008) 0.96
Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J (2010) 0.96
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target (2007) 0.95
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm (2007) 0.95
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm (2005) 0.93
Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate. Sci Pharm (2010) 0.91
Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res (2010) 0.91
Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release (2009) 0.88
Dendritic cell-based vaccine research against cancer. Expert Rev Clin Immunol (2014) 0.88
Recent advances in search of oral heparin therapeutics. Med Res Rev (2011) 0.88
Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm (2005) 0.88
Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids (2012) 0.88
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target (2006) 0.87
Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci (2008) 0.87
Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. J Pharm Pharmacol (2004) 0.86
Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target (2010) 0.86
Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm (2009) 0.85
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis. J Drug Target (2007) 0.84
Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J Biomed Nanotechnol (2011) 0.84
Gene expression, biodistribution, and pharmacoscintigraphic evaluation of chondroitin sulfate-PEI nanoconstructs mediated tumor gene therapy. ACS Nano (2009) 0.84
M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm (2009) 0.84
Engineered polyallylamine nanoparticles for efficient in vitro transfection. Pharm Res (2007) 0.83
Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opin Drug Deliv (2010) 0.83
Evaluation of anti-apoptotic activity of different dietary antioxidants in renal cell carcinoma against hydrogen peroxide. Asian Pac J Trop Biomed (2011) 0.83
Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol (2010) 0.83
Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol (2005) 0.82
Targeted nucleic acid delivery to mitochondria. Curr Gene Ther (2009) 0.82
Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection. Mol Pharm (2009) 0.82
siRNA delivery using nanocarriers - an efficient tool for gene silencing. Curr Gene Ther (2010) 0.81
Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Mol Pharm (2011) 0.81
Development and characterization of site specific target sensitive liposomes for the delivery of thrombolytic agents. Int J Pharm (2010) 0.81
Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. J Control Release (2009) 0.81
RGD modified albumin nanospheres for tumour vasculature targeting. J Pharm Pharmacol (2011) 0.81
Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting. J Drug Target (2007) 0.81
Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin. Drug Dev Ind Pharm (2010) 0.80
Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target (2011) 0.80
Platelets directed liposomes for the delivery of streptokinase: development and characterization. Eur J Pharm Sci (2011) 0.80
Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. J Liposome Res (2011) 0.80
Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives. Nanomedicine (2009) 0.80
Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm (2004) 0.80
Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Int J Pharm (2011) 0.79
Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int J Pharm (2004) 0.79
PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B. Int J Pharm (2009) 0.79
Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine (2006) 0.79
Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization. Colloids Surf B Biointerfaces (2010) 0.79
Mannosylated liposomes for targeted vaccines delivery. Methods Mol Biol (2010) 0.79
Gel core liposomes: an advanced carrier for improved vaccine delivery. J Microencapsul (2009) 0.79
Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis. Pharm Dev Technol (2011) 0.79
Retracted Various carrier system(s)- mediated genetic vaccination strategies against malaria. Expert Rev Vaccines (2008) 0.78
Potential of nanocarriers in genetic immunization. Recent Pat Drug Deliv Formul (2008) 0.78
Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Ther Pat (2010) 0.78
Efficient tumor targeting by polysaccharide decked polyethylenimine based nanocomposites. J Biomed Nanotechnol (2009) 0.78
Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation. Int J Pharm (2006) 0.78
Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm (2007) 0.78
Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA delivery. Curr Med Chem (2007) 0.78
Liposomal nanomedicine for breast cancer therapy. Nanomedicine (Lond) (2011) 0.77
Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines. Nanomedicine (Lond) (2010) 0.77
Possible role of epidermal growth factor receptors in the therapy of pancreatic cancer. Crit Rev Ther Drug Carrier Syst (2011) 0.77
Viral protein complexed liposomes for intranasal delivery of hepatitis B surface antigen. Int J Pharm (2011) 0.77
Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer. J Biomed Nanotechnol (2011) 0.77
Functionalized carriers for the improved delivery of plasminogen activators. Int J Pharm (2011) 0.77
Hepatitis B surface protein docked vesicular carrier for site specific delivery to liver. J Drug Target (2005) 0.77
Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization. J Drug Target (2012) 0.76
Tuberculosis: from molecular pathogenesis to effective drug carrier design. Drug Discov Today (2012) 0.76
Targeted delivery of doxorubicin via estrone-appended liposomes. J Drug Target (2008) 0.76
Vesicular carrier constructs for topical immunisation. Expert Opin Drug Deliv (2007) 0.76
Liposome-based drug delivery to alveolar macrophages. Expert Opin Drug Deliv (2007) 0.76
Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation. Mol Pharm (2011) 0.76
Functionalized nanocarrier(s) to image and target fungi infected immune cells. Med Mycol (2009) 0.76
Evaluation of mucoadhesive carrier adjuvant: toward an oral anthrax vaccine. Artif Cells Nanomed Biotechnol (2013) 0.76
Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Drug Deliv (2010) 0.76
Colloidal carrier systems for transcutaneous immunization. Curr Drug Targets (2011) 0.76
Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery. J Biomater Appl (2009) 0.76
Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv (2012) 0.75
Emerging role of vesicular carriers for therapy of visceral leishmaniasis: conventional versus novel. Crit Rev Ther Drug Carrier Syst (2010) 0.75
Liposomes as adjuvant for combination vaccines. Indian J Exp Biol (2007) 0.75
Nanocarriers: a versatile approach for mucosal vaccine delivery. Ther Deliv (2015) 0.75
A needle-free approach for topical immunization: antigen delivery via vesicular carrier system(s). Curr Med Chem (2007) 0.75
A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery. Drug Deliv (2014) 0.75
Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation. Int J Pharm (2006) 0.75
Aquasomes--a nanoparticulate approach for the delivery of antigen. Drug Dev Ind Pharm (2008) 0.75
Development and characterization of LTA-appended chitosan nanoparticles for mucosal immunization against hepatitis B. Artif Cells Nanomed Biotechnol (2013) 0.75